Dynamics of T Cell Receptor Distributions Following Acute Thymic Atrophy and Resumption
Stephanie M. Lewkiewicz, Yao-Li Chuang, Tom Chou

TL;DR
This study develops a mathematical model to analyze how acute thymic atrophy and subsequent recovery affect the diversity and distribution of naive T cell clones, providing insights into immune system dynamics under stress.
Contribution
The paper introduces a mean-field ODE model that captures T cell clone distribution dynamics during thymic atrophy and recovery, with analytic approximations for eigenvalues and eigenvectors.
Findings
Eigenvalues scale as a power law at low thymic output
Clone distribution dynamics depend on thymic output rate
Model predicts saturation of clone diversity at high T cell production
Abstract
Naive human T cells are produced in the thymus, which atrophies abruptly and severely in response to physical or psychological stress. To understand how an instance of stress affects the size and "diversity" of the peripheral naive T cell pool, we derive a mean-field autonomous ODE model of T cell replenishment that allows us to track the clone abundance distribution (the mean number of different TCRs each represented by a specific number of cells). We identify equilibrium solutions that arise at different rates of T cell production, and derive analytic approximations to the dominant eigenvalues and eigenvectors of the problem linearized about these equilibria. From the forms of the eigenvalues and eigenvectors, we estimate rates at which counts of clones of different sizes converge to and depart from equilibrium values--that is, how the number of clones of different sizes "adjust" to…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsT-cell and B-cell Immunology · Immune Cell Function and Interaction · Monoclonal and Polyclonal Antibodies Research
